Fundraising Fox

Yatiri Bio

San Diego, US · Founded 2021 · Delaware corporation

Yatiri Bio applies unbiased proteomics, deep learning, and patient-derived cellular models to cancer drug discovery, building a molecularly defined patient landscape to identify ideal patient subsets for novel therapeutics. It offers computational tools such as its ProteoBrowser data portal and ProteoModels cellular systems for oncology drug developers working on personalized medicine.

Founders & leadership

Yatiri Bio was founded in 2021 by Pilgrim Jackson.

PJPilgrim Jackson
Pilgrim JacksoninCo-founder & CEO
TK
toni kollerin
RA
Raman AfsharinNamed on SEC filing
MA
Mahan AbbasianinChief Operating Officer & Co-Founder
AM
Afshin MahmoudiinCo-founder & VP of Business Development

Reported raises · per SEC filings

Form D private placements

$2.9M disclosed across 2 rounds · 2021–2022

$1.2MraisedMar 2024 · 13 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mahan AbbasianExecutive Officer, Director
  • Afshin MahmoudiExecutive Officer, Director
  • Raman AfsharExecutive Officer, Director
  • Pilgrim JacksonExecutive Officer, Director
Offering amount
$7M
Amount sold
$1.2M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.7MraisedJul 2021 · 21 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pilgrim JacksonExecutive Officer, Director
  • Raman AfsharDirector
  • Mahan AbbasianDirector
  • Afshin MahmoudiDirector
Offering amount
$1.7M
Amount sold
$1.7M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Companies competing with Yatiri Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Yatiri Bio do?
Yatiri Bio applies unbiased proteomics, deep learning, and patient-derived cellular models to cancer drug discovery, building a molecularly defined patient landscape to identify ideal patient subsets for novel therapeutics. It offers computational tools such as its ProteoBrowser data portal and ProteoModels cellular systems for oncology drug developers working on personalized medicine.
Who founded Yatiri Bio?
Yatiri Bio was founded by Pilgrim Jackson in 2021.
How much funding has Yatiri Bio raised?
Yatiri Bio has disclosed $2.9M raised across 2 rounds.
Where is Yatiri Bio headquartered?
Yatiri Bio is headquartered in San Diego, US.